Brain Neurotherapy Bio, Inc.
Clinical trials sponsored by Brain Neurotherapy Bio, Inc., explained in plain language.
-
Gene therapy trial targets rare brain disease
Disease control OngoingThis early-stage trial tests a gene therapy called AAV2-GDNF for multiple system atrophy (MSA), a rare and serious brain disorder. Nine adults with MSA will receive either the gene therapy or a sham surgery. The main goal is to check safety, but researchers will also look for any…
Phase: PHASE1 • Sponsor: Brain Neurotherapy Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Gene therapy trial hopes to ease Parkinson's symptoms
Disease control OngoingThis early-stage trial tests a single dose of a gene therapy called AAV2-GDNF, delivered directly into the brain, for people with Parkinson's disease. The main goal is to check safety in 11 adults aged 35-75. Researchers will also look at whether it improves motor symptoms.
Phase: PHASE1 • Sponsor: Brain Neurotherapy Bio, Inc. • Aim: Disease control
Last updated Jun 26, 2026 19:13 UTC